CAMBRIDGE, Mass.--(BUSINESS WIRE)--Selventa™ announced today that John Tagliamonte has been appointed Senior Vice President of Corporate Development effective immediately. Mr. Tagliamonte brings over 20 years of pharmaceutical and diagnostic experience to the Selventa team. Mr. Tagliamonte’s new role includes promoting and establishing strategic partnerships with global pharmaceutical and biotechnology companies to optimize portfolio development through early patient stratification.
